Home LiteratureArticle Details
PMID: 27820798 Published · ppublish English Journal Article

DPP8 and DPP9 inhibition induces pro-caspase-1-dependent monocyte and macrophage pyroptosis.

Nature chemical biology ·Vol. 13 ·No. 1 ·2017-01-00 ·Pages 46-53

Okondo MC, Johnson DC, Sridharan R, Go EB, Chui AJ, Wang MS, Poplawski SE, Wu W, Liu Y, Lai JH, Sanford DG, Arciprete MO, Golub TR, Bachovchin WW, Bachovchin DA

Abstract

Val-boroPro (Talabostat, PT-100), a nonselective inhibitor of post-proline cleaving serine proteases, stimulates mammalian immune systems through an unknown mechanism of action. Despite this lack of mechanistic understanding, Val-boroPro has attracted substantial interest as a potential anticancer agent, reaching phase 3 trials in humans. Here we show that Val-boroPro stimulates the immune system by triggering a proinflammatory form of cell death in monocytes and macrophages known as pyroptosis. We demonstrate that the inhibition of two serine proteases, DPP8 and DPP9, activates the pro-protein form of caspase-1 independent of the inflammasome adaptor ASC. Activated pro-caspase-1 does not efficiently process itself or IL-1β but does cleave and activate gasdermin D to induce pyroptosis. Mice lacking caspase-1 do not show immune stimulation after treatment with Val-boroPro. Our data identify what is to our knowledge the first small molecule that induces pyroptosis and reveals a new checkpoint that controls the activation of the innate immune system.

MeSH Terms
Animals Boronic Acids/chemistry,pharmacology Caspase 1/deficiency,metabolism Cell Line Dipeptidases/antagonists & inhibitors,metabolism Dipeptides/chemistry,pharmacology Dipeptidyl-Peptidases and Tripeptidyl-Peptidases/antagonists & inhibitors,metabolism Dose-Response Relationship, Drug Humans Leukocytes, Mononuclear/drug effects,enzymology,pathology Macrophages/drug effects,enzymology,pathology Mice Molecular Conformation Pyroptosis/drug effects Serine Proteinase Inhibitors/chemistry,pharmacology Structure-Activity Relationship
Chemicals
Boronic Acids Dipeptides Serine Proteinase Inhibitors Dipeptidases DPP9 protein, human Dipeptidyl-Peptidases and Tripeptidyl-Peptidases DPP8 protein, human dipeptidyl peptidase 8, mouse dipeptidyl peptidase 9, mouse Caspase 1 talabostat
Authors & Affiliations
15 authors, click to expand affiliations / ORCID
Okondo Marian C
Chemical Biology Program, Memorial Sloan Kettering Cancer Center, New York, New York, USA.
Johnson Darren C
Tri-Institutional PhD Program in Chemical Biology, Memorial Sloan Kettering Cancer Center, New York, New York, USA.
Sridharan Ramya
Graduate Program in Pharmacology, Weill Cornell Graduate School of Medical Sciences, New York, New York, USA.
Go Eun Bin
Tri-Institutional PhD Program in Chemical Biology, Memorial Sloan Kettering Cancer Center, New York, New York, USA.
Chui Ashley J
Tri-Institutional PhD Program in Chemical Biology, Memorial Sloan Kettering Cancer Center, New York, New York, USA.
Wang Mitchell S
Graduate Program in Pharmacology, Weill Cornell Graduate School of Medical Sciences, New York, New York, USA.
Poplawski Sarah E
Department of Developmental, Chemical &Molecular Biology, Sackler School of Graduate Biomedical Sciences, Tufts University, Boston, Massachusetts, USA.
Wu Wengen
Department of Developmental, Chemical &Molecular Biology, Sackler School of Graduate Biomedical Sciences, Tufts University, Boston, Massachusetts, USA.
Liu Yuxin
Department of Developmental, Chemical &Molecular Biology, Sackler School of Graduate Biomedical Sciences, Tufts University, Boston, Massachusetts, USA.
Lai Jack H
Department of Developmental, Chemical &Molecular Biology, Sackler School of Graduate Biomedical Sciences, Tufts University, Boston, Massachusetts, USA.
Sanford David G
Department of Developmental, Chemical &Molecular Biology, Sackler School of Graduate Biomedical Sciences, Tufts University, Boston, Massachusetts, USA.
Arciprete Michael O
Department of Developmental, Chemical &Molecular Biology, Sackler School of Graduate Biomedical Sciences, Tufts University, Boston, Massachusetts, USA.
Golub Todd R
The Eli and Edythe L. Broad Institute, Cambridge, Massachusetts, USA. | Department of Pediatric Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA. | Harvard Medical School, Boston, Massachusetts, USA. | Howard Hughes Medical Institute, Chevy Chase, Maryland, USA.
Bachovchin William W
Department of Developmental, Chemical &Molecular Biology, Sackler School of Graduate Biomedical Sciences, Tufts University, Boston, Massachusetts, USA. | Arisaph Pharmaceuticals, Boston, Massachusetts, USA.
Bachovchin Daniel A
Chemical Biology Program, Memorial Sloan Kettering Cancer Center, New York, New York, USA. | Tri-Institutional PhD Program in Chemical Biology, Memorial Sloan Kettering Cancer Center, New York, New York, USA. | Graduate Program in Pharmacology, Weill Cornell Graduate School of Medical Sciences, New York, New York, USA.
References (46)
46 references, click to expand
  1. Immune checkpoint targeting in cancer therapy: toward combination strategies with curative potential.
    Cell. 2015 Apr 9;161(2):205-14 PMID: 25860605
  2. Nivolumab plus ipilimumab in advanced melanoma.
    N Engl J Med. 2013 Jul 11;369(2):122-33 PMID: 23724867
  3. The Dipeptidyl Peptidase Family, Prolyl Oligopeptidase, and Prolyl Carboxypeptidase in the Immune System and Inflammatory Disease, Including Atherosclerosis.
    Front Immunol. 2015 Aug 07;6:387 PMID: 26300881
  4. Cancer immunoediting: from immunosurveillance to tumor escape.
    Nat Immunol. 2002 Nov;3(11):991-8 PMID: 12407406
  5. Identification of selective and potent inhibitors of fibroblast activation protein and prolyl oligopeptidase.
    J Med Chem. 2013 May 9;56(9):3467-77 PMID: 23594271
  6. Mechanisms and functions of inflammasomes.
    Cell. 2014 May 22;157(5):1013-22 PMID: 24855941
  7. Novel isoindoline compounds for potent and selective inhibition of prolyl dipeptidase DPP8.
    Bioorg Med Chem Lett. 2005 Feb 1;15(3):687-91 PMID: 15664838
  8. Biochemical properties and expression profile of human prolyl dipeptidase DPP9.
    Arch Biochem Biophys. 2009 May 15;485(2):120-7 PMID: 19268648
  9. Unravelling the immunological roles of dipeptidyl peptidase 4 (DPP4) activity and/or structure homologue (DASH) proteins.
    Clin Exp Immunol. 2016 Jun;184(3):265-83 PMID: 26671446
  10. Safety, activity, and immune correlates of anti-PD-1 antibody in cancer.
    N Engl J Med. 2012 Jun 28;366(26):2443-54 PMID: 22658127
  11. The Dipeptidyl Peptidases 4, 8, and 9 in Mouse Monocytes and Macrophages: DPP8/9 Inhibition Attenuates M1 Macrophage Activation in Mice.
    Inflammation. 2016 Feb;39(1):413-24 PMID: 26454447
  12. Dipeptidyl peptidase 9 has two forms, a broad tissue distribution, cytoplasmic localization and DPIV-like peptidase activity.
    Biochim Biophys Acta. 2004 Jul 13;1679(1):18-28 PMID: 15245913
  13. PT-100, a small molecule dipeptidyl peptidase inhibitor, has potent antitumor effects and augments antibody-mediated cytotoxicity via a novel immune mechanism.
    Cancer Res. 2004 Aug 1;64(15):5471-80 PMID: 15289357
  14. Caspase-1 autoproteolysis is differentially required for NLRP1b and NLRP3 inflammasome function.
    Proc Natl Acad Sci U S A. 2014 Dec 2;111(48):17254-9 PMID: 25404286
  15. Hematopoietic stimulation by a dipeptidyl peptidase inhibitor reveals a novel regulatory mechanism and therapeutic treatment for blood cell deficiencies.
    Blood. 2003 Sep 1;102(5):1641-8 PMID: 12738665
  16. Caspase-11 cleaves gasdermin D for non-canonical inflammasome signalling.
    Nature. 2015 Oct 29;526(7575):666-71 PMID: 26375259
  17. Adverse effects of dipeptidyl peptidases 8 and 9 inhibition in rodents revisited.
    Diabetes Obes Metab. 2008 Nov;10(11):1057-61 PMID: 18422675
  18. Cutting Edge: Inflammasome Activation in Primary Human Macrophages Is Dependent on Flagellin.
    J Immunol. 2015 Aug 1;195(3):815-9 PMID: 26109648
  19. Inflammatory caspases are innate immune receptors for intracellular LPS.
    Nature. 2014 Oct 9;514(7521):187-92 PMID: 25119034
  20. Synthesis and activity of a potent, specific azabicyclo[3.3.0]-octane-based DPP II inhibitor.
    Bioorg Med Chem Lett. 2007 Jan 15;17(2):507-10 PMID: 17055271
  21. P2X7 receptor differentially couples to distinct release pathways for IL-1beta in mouse macrophage.
    J Immunol. 2008 Jun 1;180(11):7147-57 PMID: 18490713
  22. Structure-activity relationships of boronic acid inhibitors of dipeptidyl peptidase IV. 1. Variation of the P2 position of Xaa-boroPro dipeptides.
    J Med Chem. 1996 May 10;39(10):2087-94 PMID: 8642568
  23. Discovery and preclinical profile of Saxagliptin (BMS-477118): a highly potent, long-acting, orally active dipeptidyl peptidase IV inhibitor for the treatment of type 2 diabetes.
    J Med Chem. 2005 Jul 28;48(15):5025-37 PMID: 16033281
  24. Activation of the NLRP1b inflammasome independently of ASC-mediated caspase-1 autoproteolysis and speck formation.
    Nat Commun. 2014;5:3209 PMID: 24492532
  25. CD26 up-regulates expression of CD86 on antigen-presenting cells by means of caveolin-1.
    Proc Natl Acad Sci U S A. 2004 Sep 28;101(39):14186-91 PMID: 15353589
  26. Advances in understanding the expression and function of dipeptidyl peptidase 8 and 9.
    Mol Cancer Res. 2013 Dec;11(12):1487-96 PMID: 24038034
  27. Dipeptidyl peptidase IV inhibition for the treatment of type 2 diabetes: potential importance of selectivity over dipeptidyl peptidases 8 and 9.
    Diabetes. 2005 Oct;54(10):2988-94 PMID: 16186403
  28. Differential requirement for Caspase-1 autoproteolysis in pathogen-induced cell death and cytokine processing.
    Cell Host Microbe. 2010 Dec 16;8(6):471-83 PMID: 21147462
  29. Optimized sgRNA design to maximize activity and minimize off-target effects of CRISPR-Cas9.
    Nat Biotechnol. 2016 Feb;34(2):184-91 PMID: 26780180
  30. Biochemistry, pharmacokinetics, and toxicology of a potent and selective DPP8/9 inhibitor.
    Biochem Pharmacol. 2009 Jul 15;78(2):203-10 PMID: 19439267
  31. Cloning, expression and chromosomal localization of a novel human dipeptidyl peptidase (DPP) IV homolog, DPP8.
    Eur J Biochem. 2000 Oct;267(20):6140-50 PMID: 11012666
  32. Gasdermin D is an executor of pyroptosis and required for interleukin-1β secretion.
    Cell Res. 2015 Dec;25(12):1285-98 PMID: 26611636
  33. Identifying natural substrates for dipeptidyl peptidases 8 and 9 using terminal amine isotopic labeling of substrates (TAILS) reveals in vivo roles in cellular homeostasis and energy metabolism.
    J Biol Chem. 2013 May 17;288(20):13936-49 PMID: 23519473
  34. Identification of novel dipeptidyl peptidase 9 substrates by two-dimensional differential in-gel electrophoresis.
    FEBS J. 2015 Oct;282(19):3737-57 PMID: 26175140
  35. Investigation of the dimer interface and substrate specificity of prolyl dipeptidase DPP8.
    J Biol Chem. 2006 Dec 15;281(50):38653-62 PMID: 17040910
  36. Improved vectors and genome-wide libraries for CRISPR screening.
    Nat Methods. 2014 Aug;11(8):783-4 PMID: 25075903
  37. A high-throughput, multiplexed assay for superfamily-wide profiling of enzyme activity.
    Nat Chem Biol. 2014 Aug;10(8):656-63 PMID: 24997602
  38. Breakthrough of the year 2013. Cancer immunotherapy.
    Science. 2013 Dec 20;342(6165):1432-3 PMID: 24357284
  39. Cleavage of GSDMD by inflammatory caspases determines pyroptotic cell death.
    Nature. 2015 Oct 29;526(7575):660-5 PMID: 26375003
  40. Val-boroPro accelerates T cell priming via modulation of dendritic cell trafficking resulting in complete regression of established murine tumors.
    PLoS One. 2013;8(3):e58860 PMID: 23554941
  41. Cancer despite immunosurveillance: immunoselection and immunosubversion.
    Nat Rev Immunol. 2006 Oct;6(10):715-27 PMID: 16977338
  42. Immunology: Caspase target drives pyroptosis.
    Nature. 2015 Oct 29;526(7575):642-3 PMID: 26375000
  43. Non-canonical inflammasome activation targets caspase-11.
    Nature. 2011 Oct 16;479(7371):117-21 PMID: 22002608
  44. Fibroblast activation protein increases apoptosis, cell adhesion, and migration by the LX-2 human stellate cell line.
    Hepatology. 2005 Oct;42(4):935-45 PMID: 16175601
  45. Dipeptidyl peptidases in atherosclerosis: expression and role in macrophage differentiation, activation and apoptosis.
    Basic Res Cardiol. 2013 May;108(3):350 PMID: 23608773
  46. 1-[[(3-hydroxy-1-adamantyl)amino]acetyl]-2-cyano-(S)-pyrrolidine: a potent, selective, and orally bioavailable dipeptidyl peptidase IV inhibitor with antihyperglycemic properties.
    J Med Chem. 2003 Jun 19;46(13):2774-89 PMID: 12801240
Article Info
Journal
Nature chemical biology
Abbr.
Nat Chem Biol
ISSN
1552-4469
Published
2017-01-00
Epub
2016-00-07
Pages
46-53
Language
English
Region
United States
NLM ID
101231976
PMCID
PMC5477230
Subset
IM
Grants
NCI NIH HHS · R41 CA174008 · United States
NCI NIH HHS · T32 CA062948 · United States
NIGMS NIH HHS · T32 GM115327 · United States
NCI NIH HHS · P30 CA008748 · United States
NCI NIH HHS · R01 CA163930 · United States
NCI NIH HHS · U54 CA112962 · United States
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com